Yüklüyor......
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
OBJECTIVES: This purpose of this study was to examine clinical-pathologic factors – particularly smoking and brain metastases – in EGFR mutation positive (M+) lung adenocarcinoma (ADC) to determine their impact on survival in patients treated with first line EGFR TKI. METHODS: A retrospective review...
Kaydedildi:
Yayımlandı: | PLoS One |
---|---|
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Public Library of Science
2015
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4425557/ https://ncbi.nlm.nih.gov/pubmed/25955322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0123587 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|